Polaris Management Co. VII, L.L.C. 3

Accession 0000899243-20-029825

CIK 0001604477other

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 9:11 PM ET

Size

18.5 KB

Accession

0000899243-20-029825

Form 3

Period: 2020-10-29

10% Owner

Holdings

Series D Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (367,207 underlying)
Series B Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (849,872 underlying)
Series A Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (30,392 underlying)
Series C Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (664,097 underlying)
Series D Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (25,690 underlying)
Series A Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (434,476 underlying)
Series B Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (59,454 underlying)
Series C Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (46,458 underlying)

10% Owner

Holdings

Series A Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (30,392 underlying)
Series C Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (46,458 underlying)
Series D Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (367,207 underlying)
Series B Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (849,872 underlying)
Series C Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (664,097 underlying)
Series A Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (434,476 underlying)
Series B Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (59,454 underlying)
Series D Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (25,690 underlying)

10% Owner

Holdings

Series A Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (30,392 underlying)
Series A Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (434,476 underlying)
Series C Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (664,097 underlying)
Series D Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (367,207 underlying)
Series B Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (849,872 underlying)
Series B Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (59,454 underlying)
Series C Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (46,458 underlying)
Series D Convertible Preferred Stock
(indirect: See footnotes)
→ Common Stock (25,690 underlying)

Footnotes (4)

[F1]The Issuer's preferred stock is convertible into common stock on a 1.053 for 1 basis at the holder's election and will automatically convert upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
[F2]These shares are held of record by Polaris Entrepreneurs' Fund VII, L.P. ("EF VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of EF VII. David Barrett, Brian Chee, Amir Nashat and Bryce Youngren (the "Managing Members") are the managing members of PMC VII. Amy Schulman ("Ms. Schulman"), a member of the Issuer's board of directors, holds an interest in PMC VII.
[F3]Each of the Managing Members and Ms. Schulman, in their respective capacities with respect to PMC VII, may be deemed to have shared investment, voting and dispositive power over these shares. Each of PMC VII, the Managing Members and Ms. Schulman disclaim beneficial ownership of these shares and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
[F4]These shares are held of record by Polaris Partners VII, L.P ("PP VII"). PMC VII is the general partner of PP VII. The Managing Members are the managing members of PMC VII. Ms. Schulman, a member of the Issuer's board of directors, holds an interest in PMC VII.

Documents

1 file

SQZ Biotechnologies Co

CIK 0001604477

Entity typeother

IncorporatedDE